Surgical management of soft tissues via "ablation" therapies, in which alternative energy types (radiation, electrosurgcal, ultrasound, etc.) are applied to excise, destroy, or otherwise produce a therapeutic effect at the tissue level has undergone a proliferation in development with all of these alternatives vying for caseload in clinical applications as diverse as tumor ablation, arrhythmia [...]
Ablation technologies of different types have in common their ability to produce a therapeutic effect on human tissue. Beyond this common ground, however, there are stark differences in the modalities. Consequently, ablation technologies have variable penetration of clinical applications, with use of specific modalities for specific clinical applications driven by factors such as the tissue [...]
Manufacturers of ablation and other energy-base therapeutics are both witnessing and driving a steady evolution of multiple technologies with potential to produce therapeutic (or, in some cases, simply cosmetic) tissue effects, with different energy types competing head-on for caseload. These innovators have continued to improve their understanding of the nature of each energy type’s impact [...]
The world market for energy-based devices was well in excess of $25 billion in 2008. This represents almost 14% of the total medical device market; however, the share varies from country to country, since ablation therapy is high-technology and fairly high-cost; in poorer economies low-cost medical products such as syringes and consumables account for a [...]
Energy-based therapeutics include technologies to effect the destruction or treatment of tissues to remove pathology or otherwise modify tissue (e.g., for creating lesions that block the aberrant signals in arrhythmia). These technologies include radiofrequency, microwave, laser/light, microwave, cryo, hydromechanical, ultrasound and thermal. Some sectors of the energy-based market are growing steadily, others more rapidly. RF [...]
The worldwide high energy therapies market represents a $25 billion opportunity in 2008. The category consists of therapeutic devices and equipment that deliver the controlled application of one or more modalities of energy to tissue. The market will grow at an aggressive rate through 2017 for all modalities, but with some modalities exceeding compound annual [...]
The global market for medical devices is currently a $185 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over a 600° C temperature range of -200° [...]
Medtronic is the predominant player in the energy-based therapies market. With global sales of nearly $4.9 billion attributable to energy-based products, it controls over half of the cardiac rhythm market and almost a quarter of all energy-based product sales. Boston Scientific, also focusing on cardiac arrhythmias, comes next in the revenues table with a $2. [...]
A cursory review of data in the recent MedMarket Dilgence report #A125 reveals the countries with the highest expected growth rates in markets for ablation technologies. Based on the growth in the ablation modality segments (e.g., radiofrequency, microwave, cryosurgery, thermal, ultrasound, etc.) that comprise each country’s total ablation market, the countries with the highest ablation [...]
[Insight: One of the more fascinating aspects of medical technology development is the penchant in the industry for finding different ways to accomplish traditional tasks in medical and surgical care. While certainly some technologies can be oversold for their putative clinical benefits --- driving up healthcare costs and giving the industry a bad rap --- [...]
Contact:
